Plus Therapeutics, Inc.
PSTV
$0.2025
-$0.1061-34.38%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.87M | 3.61M | 4.79M | 8.44M | 3.22M |
| Total Receivables | -- | 571.00K | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 557.00K | 646.00K | 576.00K | 945.00K | 989.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 444.00K | 436.00K | -- | -- | -- |
| Total Current Assets | 10.87M | 5.26M | 5.36M | 9.38M | 4.21M |
|
|
|||||
| Total Current Assets | 10.87M | 5.26M | 5.36M | 9.38M | 4.21M |
| Net Property, Plant & Equipment | 362.00K | 521.00K | 697.00K | 871.00K | 971.00K |
| Long-term Investments | 372.00K | 372.00K | 372.00K | 372.00K | 372.00K |
| Goodwill | 372.00K | 372.00K | 372.00K | 372.00K | 372.00K |
| Total Other Intangibles | 435.00K | 469.00K | 513.00K | 557.00K | 33.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.00K | 12.00K | 32.00K | 32.00K | 32.00K |
| Total Assets | 12.06M | 6.63M | 6.98M | 11.21M | 5.62M |
|
|
|||||
| Total Accounts Payable | 9.22M | 9.47M | 7.91M | 6.95M | 6.45M |
| Total Accrued Expenses | -- | 1.81M | -- | -- | -- |
| Short-term Debt | -- | 3.29M | 3.29M | 3.29M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 40.00K | 44.00K | 68.00K | 92.00K | 3.71M |
| Total Finance Division Other Current Liabilities | 1.30M | 927.00K | 840.00K | 8.46M | 247.00K |
| Total Other Current Liabilities | 1.30M | 927.00K | 840.00K | 8.46M | 247.00K |
| Total Current Liabilities | 10.56M | 15.55M | 12.11M | 18.79M | 10.40M |
|
|
|||||
| Total Current Liabilities | 10.56M | 15.55M | 12.11M | 18.79M | 10.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 3.29M | 3.29M | 3.29M | -- |
| Capital Leases | -- | 31.00K | 40.00K | 50.00K | 59.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 25.14M | -- | -- | -- | -- |
| Total Liabilities | 35.70M | 15.58M | 12.15M | 18.84M | 10.46M |
|
|
|||||
| Common Stock & APIC | 487.74M | 485.03M | 484.90M | 479.58M | 479.43M |
| Retained Earnings | -510.88M | -493.48M | -489.58M | -486.70M | -483.76M |
| Treasury Stock & Other | -500.00K | -500.00K | -500.00K | -500.00K | -500.00K |
| Total Common Equity | -23.64M | -8.95M | -5.17M | -7.63M | -4.84M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -23.64M | -8.95M | -5.17M | -7.63M | -4.84M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -23.64M | -8.95M | -5.17M | -7.63M | -4.84M |
|
|
|||||